Multivariate Cox regression analysis showed that the p‐AKT1/nuclear IRF3 score was an independent prognostic factor for the DFS and OS of ER+ HER2– breast cancer patients (Figure 6I; and Figure S6H, Supporting Information). This evidence concerns the gene IRF3 and breast cancer.